loadpatents
name:-0.033695220947266
name:-0.026037931442261
name:-0.00091195106506348
ENGLEMAN; Edgar G. Patent Filings

ENGLEMAN; Edgar G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ENGLEMAN; Edgar G..The latest application filed is for "method for treating neurodegenerative diseases".

Company Profile
0.26.27
  • ENGLEMAN; Edgar G. - Redwood City CA
  • ENGLEMAN; Edgar G. - Atherton CA
  • ENGLEMAN; Edgar G - Redwood City CA
  • Engleman; Edgar G. - Palo Alto CA
  • Engleman; Edgar G. - Stanford CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For Treating Neurodegenerative Diseases
App 20210283108 - NGUYEN; Khoa Dinh ;   et al.
2021-09-16
Method for treating neurodegenerative diseases
Grant 10,966,962 - Nguyen , et al. April 6, 2
2021-04-06
Method For Preventing And/or Treating Aging-associated Cognitive Impairment And Neuroinflammation
App 20210059985 - NGUYEN; Khoa Dinh ;   et al.
2021-03-04
Method For Treating Neurodegenerative Diseases
App 20200163941 - NGUYEN; Khoa Dinh ;   et al.
2020-05-28
Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation
Grant 10,653,669 - Nguyen , et al.
2020-05-19
Method for treating neurodegenerative diseases
Grant 10,583,125 - Nguyen , et al.
2020-03-10
Method For Treating Neurodegenerative Diseases
App 20190365716 - Nguyen; Khoa Dinh ;   et al.
2019-12-05
Method for treating neurodegenerative diseases
Grant 10,272,070 - Nguyen , et al.
2019-04-30
Method For Preventing And/or Treating Aging-associated Cognitive Impairment And Neuroinflammation
App 20180353474 - NGUYEN; Khoa Dinh ;   et al.
2018-12-13
Method For Treating Neurodegenerative Diseases
App 20170304269 - NGUYEN; Khoa Dinh ;   et al.
2017-10-26
Reversing intestinal inflammation by inhibiting retinoic acid metabolism
Grant 9,248,120 - Penny , et al. February 2, 2
2016-02-02
Compositions and methods for treating diseases
Grant 9,220,744 - Rothbard , et al. December 29, 2
2015-12-29
Compositions and methods for treating diseases
App 20140342986 - Rothbard; Jonathan B. ;   et al.
2014-11-20
Compositions and methods for treating diseases
Grant 8,629,115 - Rothbard , et al. January 14, 2
2014-01-14
Reversing Intestinal Inflammation by Inhibiting Retinoic Acid Metabolism
App 20130131129 - Leong; Hwei Xian ;   et al.
2013-05-23
Compositions and methods for treating diseases
App 20110124584 - Rothbard; Jonathan B. ;   et al.
2011-05-26
Compositions and methods for treating diseases
Grant 7,820,626 - Rothbard , et al. October 26, 2
2010-10-26
Ligand (act-4-l) To A Receptor On The Surface Of Activated Cd4+ Tcells
App 20100240873 - Godfrey; Wayne ;   et al.
2010-09-23
Compositions and methods for treating diseases
Grant 7,557,087 - Rothbard , et al. July 7, 2
2009-07-07
Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells
App 20090069535 - GODFREY; WAYNE ;   et al.
2009-03-12
Compositions And Methods For Treating Diseases
App 20090053283 - Rothbard; Jonathan B. ;   et al.
2009-02-26
Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae
App 20080214480 - Yu; Chen M. ;   et al.
2008-09-04
Antibody to receptor on the surface of activated T-cells: ACT-4
Grant 7,364,733 - Godfrey , et al. April 29, 2
2008-04-29
Compositions and Methods for Treating Diseases
App 20070185203 - Rothbard; Jonathan B. ;   et al.
2007-08-09
Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
App 20070092511 - Godfrey; Wayne ;   et al.
2007-04-26
Receptor on the surface of activated T-cells: ACT-4
App 20070077247 - Godfrey; Wayne ;   et al.
2007-04-05
Ligand (ACT-4-L) to a receptor on the surface of activated CD4.sup.+T-cells
Grant 7,125,670 - Godfrey , et al. October 24, 2
2006-10-24
Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
App 20060217531 - Godfrey; Wayne ;   et al.
2006-09-28
Method of treating rheumatoid arthritis and multiple sclerosis diseases of the human immune system
Grant 7,098,184 - Godfrey , et al. August 29, 2
2006-08-29
Compositions and methods for treating diseases
App 20050192210 - Rothbard, Jonathan B. ;   et al.
2005-09-01
Receptor on the surface of activated T-cells: ACT-4
App 20040265866 - Godfrey, Wayne ;   et al.
2004-12-30
Methods for using dendritic cells to activate gamma/delta-T cell receptor-positive T cells
Grant 6,821,778 - Engleman , et al. November 23, 2
2004-11-23
Receptor on the surface of activated T-cells: ACT-4
App 20040136995 - Godfrey, Wayne ;   et al.
2004-07-15
Ligant (ACT-4-L) to a receptor on the surface of activated CD4+T-cells
App 20040006207 - Godfrey, Wayne ;   et al.
2004-01-08
Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
App 20030149247 - Godfrey, Wayne ;   et al.
2003-08-07
Methods of administering antibodies that specifically bind ACT-4-L-h-1 ligand
Grant 6,528,055 - Godfrey , et al. March 4, 2
2003-03-04
Antibodies that specifically bind ACT-4-L-h-1 ligand
Grant 6,528,623 - Godfrey , et al. March 4, 2
2003-03-04
Adjuvant treatment by in vivo activation of dendritic cells
Grant 6,423,539 - Fong , et al. July 23, 2
2002-07-23
Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
App 20020077460 - Godfrey, Wayne ;   et al.
2002-06-20
Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
App 20010044523 - Godfrey, Wayne ;   et al.
2001-11-22
Receptor on the surface of activated T-cells: ACT-4
App 20010044522 - Godfrey, Wayne ;   et al.
2001-11-22
Adjuvant treatment by in vivo activation of dendritic cells
App 20010036462 - Fong, Lawrence H. ;   et al.
2001-11-01
Receptor on the surface of activated t-cells: act-4
Grant 6,277,962 - Godfrey , et al. August 21, 2
2001-08-21
Ligand (ACT-4-L) to a receptor on the surface of activated CD4.sup.+ T-cells
Grant 6,156,878 - Godfrey , et al. December 5, 2
2000-12-05
Receptor on the surface of activated CD4.sup.+ T-cells: ACT-4
Grant 5,821,332 - Godfrey , et al. October 13, 1
1998-10-13
Treatment of systemic lupus erythematosus with dehydroepiandrosterone
Grant 5,567,696 - McGuire , et al. October 22, 1
1996-10-22
Natural killer cell lines and clones with antigen specificity
Grant 5,415,874 - Bender , et al. May 16, 1
1995-05-16
Non-human primate monoclonal antibodies and methods
Grant 4,777,245 - Foung , et al. October 11, 1
1988-10-11
Human-murine hybridoma fusion partner
Grant 4,634,666 - Engleman , et al. January 6, 1
1987-01-06
Method for HLA-DR typing of total human lymphocyte sample
Grant 4,471,056 - Grumet , et al. September 11, 1
1984-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed